Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
01/2011
01/13/2011US20110009478 Theranostic polycation beacons comprising oligoethyleneamine repeating units and lanthanide chelates
01/13/2011US20110009471 Oligonucleotide analogues and methods utilizing the same
01/13/2011US20110009467 Methods to Increase or Decrease Bone Density
01/13/2011US20110008842 Novel chimeric tnf ligands
01/13/2011US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter
01/13/2011US20110008792 Promoters for expression in modified vaccinia virus ankara
01/13/2011CA2805403A1 Bioengineered silk protein-based nucleic acid delivery systems
01/13/2011CA2804602A1 Codon-optimized factor viii variants and synthetic liver-specific promoter
01/13/2011CA2803525A1 Aptamer-targeted sirna to inhibit nonsense mediated decay
01/13/2011CA2767621A1 Sparc antisense compositions and uses thereof
01/13/2011CA2767367A1 The use of two micrornas in lung cancer prognosis and drug preparation
01/13/2011CA2767148A1 Process for the identification of compounds for treating cancer
01/13/2011CA2765694A1 Amphoteric liposomes comprising imino lipids
01/12/2011EP2272985A1 Antisense modulation of apolipoprotein (A) expression
01/12/2011EP2272960A1 Human protein NELL2 gene
01/12/2011EP2272950A2 Defective influenza virus particles
01/12/2011EP2272857A1 Modulation of glucagon receptor expression
01/12/2011EP2272529A2 DNA vaccine combined with an inducer of tumor cell apoptosis
01/12/2011EP2272528A2 DNA vaccine combined with an inducer of tumor cell apoptosis
01/12/2011EP2272527A2 Combined DNA vaccine and biological modifiers for cancer therapy
01/12/2011EP2272526A2 Adjuvant for transcutaneous immunization
01/12/2011EP2271768A2 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung
01/12/2011EP2271370A2 Compositions and methods for diagnosing and treating melanoma
01/12/2011EP2271369A1 Novel therapeutical tools and methods for treating blindness
01/12/2011EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
01/12/2011EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method
01/12/2011CN1826411B Promoter construct for gene expression in neuronal cells
01/12/2011CN101946001A Polypeptide-nucleic acid conjugates and uses thereof
01/12/2011CN101942481A Construction and application of recombined lentivirus vector aiming at RNA interference of PKC gamma genes
01/12/2011CN101942475A Micro-loop free expression vector and construction method and application thereof
01/12/2011CN101942444A Small RNA for human and rat-homologous NMDA receptor NR2B and application thereof
01/12/2011CN101942443A Novel beta-actin and rps21 promoters and uses thereof
01/12/2011CN101942442A Novel beta-actin and rps21 promoters and uses thereof
01/12/2011CN101942441A Structure and application of siRNA for suppressing proliferation and metastasis of human lung cancer cells
01/12/2011CN101942418A 333rd amino acid mutant strain of rabies virus Flury-LEP glycoprotein
01/12/2011CN101942017A Novel tumor marker
01/12/2011CN101940796A Preparation of gene immunization treating tumor used for vein
01/12/2011CN101940795A Applications of DLK1 gene, siRNA (small interference Ribonucleic Acid), BM-MSCs (Bone Marrow Mesenchymal Stem Cells) and FGF2 (Fibroblast Growth Factor2)
01/12/2011CN101940794A Csk binding protein inhibitor and application thereof
01/12/2011CN101940786A Application of immunogenic protein gene PilA of haemophilus parasuis
01/12/2011CN101940783A Application of DNAzyme in preparing medicines for enhancing tumor chemotherapy sensitivity
01/12/2011CN101940551A Self-assembly nano-particles of sulfhydrylation chitosan quaternary ammonium salt and preparation method and application thereof
01/12/2011CN101200483B Antisense nucleic acid of resistant and tolerant dimethoxyphenecillin staphylococcus aureus drug resistant gene
01/12/2011CN101148473B Recombination human insulin and its coding gene and application
01/11/2011US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes
01/11/2011US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune
01/11/2011US7867974 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal
01/11/2011US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity
01/11/2011CA2309541C Vegi, an inhibitor of angiogenesis and tumor growth
01/11/2011CA2286313C Novel ldl-receptor
01/11/2011CA2263848C New systems for the regulation of gene expression
01/06/2011WO2011002077A1 Tnf-α gene therapy agent contained in polymeric micelle
01/06/2011WO2011002070A1 Pharmaceutical composition for treating iron overload disorders or diseases on which the reduction in iron concentration is effective, which comprises gdf7/bmp12 protein
01/06/2011WO2011001882A1 Flagellin mutant capable of effectively inducing protective capability on infection by pseudomonas aeruginosa
01/06/2011WO2010123699A3 Compositions, kits and methods for promoting ischemic and diabetic wound healing
01/06/2011WO2010093904A3 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
01/06/2011WO2010033285A3 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells
01/06/2011US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase
01/06/2011US20110003883 Allosteric trans-splicing group i ribozyme whose activity of target-specific rna replacement is controlled by theophylline
01/06/2011US20110003381 Viral vectors and host cells and methods of making and using them
01/06/2011US20110003378 MULTIPLE PROMOTER EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS
01/06/2011US20110003318 Nucleotide and protein sequence of mammastatin and methods of use
01/06/2011US20110003307 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
01/06/2011US20110002996 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue
01/06/2011US20110002980 Vaccines using nucleic acid-lipid complexes
01/06/2011US20110002956 Mutant human cd80 and compositions for and methods of making and using the same
01/06/2011US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination
01/06/2011US20110002919 Antagonists of neuropilin receptor function and use thereof
01/06/2011US20110002910 Therapeutic agents comprising pro-apoptotic proteins
01/06/2011US20110002890 Treatment of tumors with genetically engineered herpes virus
01/05/2011EP2270513A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
01/05/2011EP2270230A2 Antisense modulation of insulin-like growth factor binding protein 5 expression
01/05/2011EP2270209A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
01/05/2011EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
01/05/2011EP2270162A2 Conserved HBV and HCV sequences useful for gene silencing
01/05/2011EP2270161A2 Multiple RNA polymerase III promoter expression constructs
01/05/2011EP2270159A1 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
01/05/2011EP2270027A1 Polypeptides having brain-localizing activity and uses thereof
01/05/2011EP2270024A1 Antisense modulation of superoxide dismutase 1, soluble expression
01/05/2011EP2269658A1 Gene therapy for neurometabolic disorders
01/05/2011EP2269628A2 Pancreas-specific proteins
01/05/2011EP2269461A1 Treating cardiovascular tissue
01/05/2011EP2268798A1 Method for obtaining ngn3-expressing cells and insulin producing-beta cells
01/05/2011EP2268316A2 NOVEL siRNA COMPOUNDS FOR INHIBITING RTP801
01/05/2011EP1747023B1 Methods and compositions for reducing hcv viral genome amounts in a target cell
01/05/2011EP1723417B1 C20orf23 as modifier of the igfr pathway and methods of use
01/05/2011EP1706489B9 Oligomeric compounds for the modulation of bcl-2
01/05/2011EP1663315B1 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
01/05/2011EP1546322B1 Transposon-based vectors and methods of nucleic acid integration
01/05/2011EP0815129B1 Ingap protein involved in pancreatic islet neogenesis
01/05/2011CN1703229B Compositions and uses for treatment of prostate and other cancers
01/05/2011CN101935687A Application of IL-12p40 siRNA to promoting liver regeneration
01/05/2011CN101935674A Adenovirus vector for gene therapy on hemophilia B and application thereof
01/05/2011CN101935673A Method for promoting liver regeneration by adjusting GAT-1 expression
01/05/2011CN101935659A MiRNA for female ascaris suum adult specificity expression and application thereof
01/05/2011CN101935658A MiRNA specially expressed in adult male ascaris suums and use thereof
01/05/2011CN101935656A Gene for promoting insulin secretion, preparation method and application thereof
01/05/2011CN101935651A siRNA module of targeted Survivin gene and application thereof
01/05/2011CN101935650A siRNA (Small interfering Ribonucleic Acid) molecule for interfering Survivin expression and application thereof
01/05/2011CN101935649A SiRNA (Small Interfering RNA) molecule capable of suppressing Survivin expression and application thereof